These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8477565)

  • 21. Perindopril: an updated review of its use in hypertension.
    Hurst M; Jarvis B
    Drugs; 2001; 61(6):867-96. PubMed ID: 11398915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril].
    Forette F; McClaran JM; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():79-85. PubMed ID: 2505717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Hypertension: Favourable Effect of the Twice-Daily Compared to the Once-Daily (Evening) Administration of Perindopril and Losartan.
    Szauder I; Csajági E; Major Z; Pavlik G; Ujhelyi G
    Kidney Blood Press Res; 2015; 40(4):374-85. PubMed ID: 26160625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring.
    Asmar RG; Pannier BM; Santoni JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S79-81. PubMed ID: 3225692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Captopril versus perindopril: a double blind study in essential hypertension.
    Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
    J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure.
    MacFadyen RJ; Barr CS; Sturrock ND; Fenwick M; Struthers AD
    Br J Clin Pharmacol; 1997 Jul; 44(1):69-76. PubMed ID: 9241099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia.
    Middeke M; Krone W
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):629-31. PubMed ID: 7516014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparison of perindopril and hydrochlorothiazide-amiloride in mild to moderate essential hypertension.
    Andrejak M; Santoni JP; Carré A; Deruyttere M; Magometschnigg D; Gotzen R; Stumpe KO
    Fundam Clin Pharmacol; 1991; 5(3):185-92. PubMed ID: 1682228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacology of perindopril.
    Lees KR
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():7-8; discussion 9-11. PubMed ID: 2283658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects.
    Louis WJ; Workman BS; Conway EL; Worland P; Rowley K; Drummer O; McNeil JJ; Harris G; Jarrott B
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):505-11. PubMed ID: 1279299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perindopril/hydrochlorothiazide dose combinations for the treatment of hypertension: a multicenter study.
    Chrysant SG
    J Clin Pharmacol; 1997 Jan; 37(1):47-52. PubMed ID: 9048272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between an angiotensin converting enzyme inhibitor, perindopril, and a thiazide diuretic in the spontaneously hypertensive rat.
    Scalbert E; Abdon D; Devissaguet M; Juggi JS
    Can J Cardiol; 1992 May; 8(4):381-6. PubMed ID: 1617521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension.
    West JN; Smith SA; Stallard TJ; Littler WA
    J Hypertens; 1989 Feb; 7(2):97-104. PubMed ID: 2647846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
    Widimský J; Fedelesová V; Uhlír O
    Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
    Nalbantgil I; Nalbantgil S; Ozerkan F; Yilmaz H; Gürgün C; Zoghi M; Aytimur M; Onder R
    Int J Clin Pract Suppl; 2004 Dec; (145):50-4. PubMed ID: 15617460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the dose-effect relationship of perindopril in the treatment of hypertension.
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Clin Exp Hypertens A; 1989; 11 Suppl 2():521-34. PubMed ID: 2605801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Todd PA; Fitton A
    Drugs; 1991 Jul; 42(1):90-114. PubMed ID: 1718688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.